We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Peabody Energy
BTU
$2.94B
| $255K | ﹤0.01% |
11,771
-78,506
| -87% | -$1.74M |
|
2677
Invesco MSCI Global Timber ETF
CUT
$33.5M
| $255K | ﹤0.01% |
+8,648
| New | +$256K |
|
|
ECF
2678
Ellsworth Growth & Income Fund
ECF
$178M
| $255K | ﹤0.01% |
29,595
+2,203
| +8% | +$17.9K |
|
|
MTA
2679
Metalla Royalty & Streaming
MTA
$848M
| $255K | ﹤0.01% |
58,824
+12,963
| +28% | +$61.9K |
|
2680
California Water Service
CWT
$3.1B
| $254K | ﹤0.01% |
4,920
+1
| +0% | +$56 |
|
2681
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.78B
| $254K | ﹤0.01% |
8,691
-703
| -7% | -$20.6K |
|
2682
iShares China Large-Cap ETF
FXI
$4.16B
| $254K | ﹤0.01% |
9,327
-559
| -6% | -$15.7K |
|
2683
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$389M
| $254K | ﹤0.01% |
3,246
-2,518
| -44% | -$185K |
|
2684
CRH
CRH
$65B
| $252K | ﹤0.01% |
4,514
+400
| +10% | +$20K |
|
2685
iShares Core 5-10 Year USD Bond ETF
IMTB
$276M
| $251K | ﹤0.01% |
5,826
-14,241
| -71% | -$619K |
|
2686
AdvisorShares Pure US Cannabis ETF
MSOS
$934M
| $251K | ﹤0.01% |
45,255
-9,162
| -17% | -$50.2K |
|
2687
Impinj
PI
$5.46B
| $251K | ﹤0.01% |
2,801
+941
| +51% | +$100K |
|
2688
Amplify CEF High Income ETF
YYY
$746M
| $251K | ﹤0.01% |
21,474
+773
| +4% | +$8.96K |
|
2689
Bruker
BRKR
$8.83B
| $250K | ﹤0.01% |
3,381
-100
| -3% | -$7.62K |
|
2690
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$64.1M
| $250K | ﹤0.01% |
6,760
-162
| -2% | -$6.16K |
|
2691
Murphy Oil
MUR
$4.99B
| $250K | ﹤0.01% |
6,521
-1,035
| -14% | -$38.2K |
|
2692
NovoCure
NVCR
$2.02B
| $250K | ﹤0.01% |
6,029
+807
| +15% | +$50.1K |
|
2693
Timothy Plan International ETF
TPIF
$266M
| $250K | ﹤0.01% |
9,913
+1,106
| +13% | +$27.8K |
|
2694
Under Armour
UAA
$2.3B
| $250K | ﹤0.01% |
34,684
+1,594
| +5% | +$12.8K |
|
|
DX
2695
Dynex Capital
DX
$3.23B
| $249K | ﹤0.01% |
19,816
-664
| -3% | -$7.76K |
|
2696
Collegium Pharmaceutical
COLL
$913M
| $248K | ﹤0.01% |
11,549
-303,957
| -96% | -$6.9M |
|
2697
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.31B
| $247K | ﹤0.01% |
11,664
-838
| -7% | -$17.9K |
|
2698
Trex
TREX
$5.1B
| $247K | ﹤0.01% |
+3,761
| New | +$210K |
|
2699
Webster Financial
WBS
$12.8B
| $247K | ﹤0.01% |
6,533
-951
| -13% | -$35.1K |
|
2700
AllianzIM U.S. Equity Buffer20 Feb ETF
FEBW
$200M
| $246K | ﹤0.01% |
9,300
| – | – |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.